HC Advisors’s Merck MRK Stock Holding History

HC Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$210K	Buy	+1,635	New	+$191K	0.13%	59
2025 Q1	–	Sell	-2,010	Closed	-$200K	–	65
2024 Q4	$200K	Buy	+2,010	New	+$207K	0.16%	54

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HC Advisors's MRK Position: Q2 2026 in Review

HC Advisors opened a new position in Merck (MRK) in Q2 2026: 1,635 shares worth $210K. The stake represents 0.13% of the portfolio and ranks #59 among its holdings. This is a return to the name: HC Advisors previously reported a position in MRK as recently as Q4 2024.

HC Advisors first reported a position in MRK in Q4 2024 and has held it in 2 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

HC Advisors held 1,635 shares of Merck worth $210K as of Q2 2026.
Merck was a new HC Advisors position in Q2 2026.
Merck made up 0.13% of HC Advisors's portfolio in Q2 2026, its #59 holding.
HC Advisors first reported a position in Merck in Q4 2024 and has held it in 2 quarters since.
3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on HC Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.